Har Grover, MBA, ICD.D

Mr. Har Grover is an entrepreneur, investor, senior executive and strategist with over 30 years of experience in healthcare, life sciences and technology. He has worked with growth companies at all stages, from start-up to commercialization, to going public and growing through the $1 billion revenue mark. He has helped companies enter new markets both in Canada and internationally – organically and through M&A, strategic alliances, and joint ventures.

Mr. Grover is currently the Executive Chairman and CEO of Scientus Pharma. He was previously Co-Founder of CannScience Innovations, as well as Founder and Managing Director of Nucleus GC, a Toronto-based professional services and investment company specializing in life sciences markets.

He has served on several corporate and non-profit boards, including Chair of Armour Therapeutics, Chair of Crohn’s and Colitis Canada, Board Director of Medworxx, and Board Director of MedcannAccess. Mr. Grover has an undergraduate degree in life sciences, an MBA, and has obtained professional CMC and ICD.D designations.

Other Team Members

Shana Kelley, PhD

Founder and CEO, Xagenic Inc.

John Morrison, BSc

Former Group President, Healthcare, MDS Inc.

Kevin Empey, CPA, ICD.D

Supervisor, Brockville General Hospital

Ken Lawless, MSc

President and CEO, Epitope Capital Corp.